Delivery Order SPE2DE21D0005-SPE2D625F709A

Award Date 11/13/24
Potential Completion Date 11/18/24
Potential Value $2.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F709A
    Delivery Order

This federal contract award, valued at $2,479.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The delivery order is for APLIGRAF, an advanced wound care product used to support medical treatments for military personnel and veterans.

Organogenesis has a strong presence in government medical procurement, holding several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up to $49.5 million, for a range of wound care dressings, surgical implants, and tissue regeneration products. While this specific award does not utilize a set-aside designation, Organogenesis has been a recipient of contracts through small business programs. The delivery order supports the military medical supply chain, contributing to the availability of cutting-edge regenerative medicine solutions for service members and veterans.

Generated 2/12/25, 9:26 AM